Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China
· Delayed Price · Currency is CNY 6.61
+0.23 (3.61%)
Jul 7, 2025, 3:04 PM CST
SHE:000952 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -281.05 | -295.29 | -140.25 | 50.33 | 110.11 | 74.65 | Upgrade
|
Depreciation & Amortization | 165.14 | 165.14 | 119.95 | 98.31 | 91.26 | 90.44 | Upgrade
|
Other Amortization | 1.92 | 1.92 | 0.77 | 0.01 | 0.12 | 0.24 | Upgrade
|
Loss (Gain) From Sale of Assets | 2.4 | 2.4 | -0.25 | 4.31 | -0.54 | -0.18 | Upgrade
|
Asset Writedown & Restructuring Costs | 30.68 | 30.68 | 0.12 | 12.28 | 1.15 | 5.84 | Upgrade
|
Loss (Gain) From Sale of Investments | 27.92 | 27.92 | 9.24 | -6.3 | -18.72 | -32.17 | Upgrade
|
Provision & Write-off of Bad Debts | -2.8 | -2.8 | 0.14 | - | - | - | Upgrade
|
Other Operating Activities | 81.21 | 47.8 | 46.89 | 14.12 | 13.91 | 31.42 | Upgrade
|
Change in Accounts Receivable | 156.17 | 156.17 | -53.06 | -102.06 | -66.93 | 475.86 | Upgrade
|
Change in Inventory | -14.16 | -14.16 | -100.18 | -64.33 | -4.35 | -26.84 | Upgrade
|
Change in Accounts Payable | -114.2 | -114.2 | -44.87 | 29.87 | -47.38 | -495.73 | Upgrade
|
Change in Other Net Operating Assets | 0.12 | 0.12 | 0.91 | 10.83 | - | - | Upgrade
|
Operating Cash Flow | 48.31 | 0.66 | -148.96 | 45.08 | 75.91 | 119.38 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -40.61% | -36.42% | -17.21% | Upgrade
|
Capital Expenditures | -135.93 | -154.93 | -566.13 | -203.71 | -96.61 | -97.89 | Upgrade
|
Sale of Property, Plant & Equipment | 2.16 | 2.16 | 0.35 | 0 | 0.74 | 0.21 | Upgrade
|
Divestitures | 44.79 | - | - | - | - | 41.37 | Upgrade
|
Investment in Securities | - | - | - | 80 | -20 | -60 | Upgrade
|
Other Investing Activities | - | - | - | 1.97 | 1.76 | 3.5 | Upgrade
|
Investing Cash Flow | -88.99 | -152.78 | -565.78 | -121.74 | -114.1 | -112.82 | Upgrade
|
Short-Term Debt Issued | - | - | 20 | - | - | - | Upgrade
|
Long-Term Debt Issued | - | 766.31 | 1,221 | 739.45 | 388.65 | 455.36 | Upgrade
|
Total Debt Issued | 946.91 | 766.31 | 1,241 | 739.45 | 388.65 | 455.36 | Upgrade
|
Long-Term Debt Repaid | - | -660.49 | -559.51 | -438.48 | -399.77 | -693.88 | Upgrade
|
Total Debt Repaid | -829.32 | -660.49 | -559.51 | -438.48 | -399.77 | -693.88 | Upgrade
|
Net Debt Issued (Repaid) | 117.59 | 105.82 | 681.09 | 300.97 | -11.12 | -238.51 | Upgrade
|
Issuance of Common Stock | - | - | - | 36.19 | - | 364 | Upgrade
|
Repurchase of Common Stock | -14.51 | -14.51 | -0.44 | - | - | - | Upgrade
|
Common Dividends Paid | -51.35 | -50.46 | -31.56 | -40.24 | -35.65 | -49.52 | Upgrade
|
Other Financing Activities | 6.4 | 2 | 52 | 4.02 | - | 27.17 | Upgrade
|
Financing Cash Flow | 58.13 | 42.84 | 701.09 | 300.94 | -46.77 | 103.14 | Upgrade
|
Foreign Exchange Rate Adjustments | 1.16 | 1.21 | 0.12 | 1.43 | -1.5 | -3.81 | Upgrade
|
Net Cash Flow | 18.62 | -108.07 | -13.54 | 225.71 | -86.47 | 105.89 | Upgrade
|
Free Cash Flow | -87.62 | -154.28 | -715.1 | -158.63 | -20.7 | 21.49 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | - | -12.08% | Upgrade
|
Free Cash Flow Margin | -14.43% | -24.15% | -96.92% | -19.89% | -2.63% | 3.12% | Upgrade
|
Free Cash Flow Per Share | -0.25 | -0.44 | -2.02 | -0.45 | -0.06 | 0.06 | Upgrade
|
Cash Income Tax Paid | - | -33.62 | 20.53 | 8.91 | 37.53 | 20.15 | Upgrade
|
Levered Free Cash Flow | 44.43 | -72.68 | -515.16 | -137.81 | -64.25 | 47.88 | Upgrade
|
Unlevered Free Cash Flow | 83.54 | -33.95 | -484.44 | -124.63 | -53.81 | 67.85 | Upgrade
|
Change in Net Working Capital | -183.27 | -93.49 | -19.64 | 59.85 | 103.12 | -22.58 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.